Relizen Hot Flash & Night Sweat Relief Tablets by Bonafide
A focused daily supplement for hot flashes and night sweats, built around purified Swedish flower pollen extract in a simple two-tablet routine.
Relizen Hot Flash & Night Sweat Relief Tablets earns a GenMeno score of 87 because its standardized PI-82 and GC-FEM pollen extract blend has direct placebo-controlled support for hot flashes, and the 320 mg daily total matches the dose used in published studies. This is a strong, focused option for women whose main concerns are hot flashes and night sweats, although the current label does not disclose the amount of each extract.
- Package60 tablets
- Serving2 tablets daily
- SupplyAbout 30 days
- Typical Price$58 one-time; plans from $38/month
- Available FromAmazon and Bonafide
- ✓You want focused support for hot flashes and night sweats
- ✓You want a formula built around one studied pollen extract blend
- ✓You are comfortable using it consistently before judging results
- –You want the exact amount of every active extract disclosed
- –You need fast or as-needed relief
- –Your main priorities fall outside hot flashes and night sweats
See the full breakdown
- 320 mg daily total matches the dose used in published studies
- A randomized, double-blind trial found greater hot flash improvement than placebo
- Additional human studies support the ingredient's hot flash focus
- Simple two-tablet once-daily routine
- Relizen does not disclose the individual PI-82 and GC-FEM amounts
This review may contain affiliate links. If you purchase through them, GenMeno may earn a commission at no extra cost to you. We review products using publicly available labels, retailer information, brand materials, and, when needed, purchased samples or brand-provided samples. Our scores and conclusions are independent of how we received them. How GenMeno reviews products →
Relizen for Hot Flashes and Menopause Symptoms
The ingredient evidence is most relevant to hot flashes and night sweats. It may also be relevant when night sweats are disrupting sleep.
- Hot flashes
- Night sweats
- Brain fog or mood
- Weight changes or joint pain
- Vaginal dryness or libido
- Skin or hair changes
What you need to know before buying
The studies behind this ingredient used a standardized blend of PI-82 and GC-FEM at 320 mg daily. PI-82 makes up 75% of that formula, GC-FEM the remaining 25%. Relizen matches the total dose, but the label doesn't break out how much of each extract it contains.
- A one-time 60-tablet box is $58. The monthly plan is $42 per month, a 27% discount, while the three-month plan is $38 per month, a 34% discount.
- Qualified shoppers can use pre-tax HSA/FSA funds through Bonafide's Truemed partnership after completing its eligibility process.
- Returns are limited to unopened, unused products. First-time orders have a 30-day return window; recurring orders have a 14-day window. Bonafide deducts a $7 return shipping fee from refunds.
If hot flashes and night sweats are the symptoms you most want to address, and you prefer a focused formula over a broad multi-symptom blend, Relizen is a strong fit to consider. Its 320 mg daily pollen extract total matches the dose used in published studies, and Bonafide's subscription options make the ongoing routine less expensive than buying one box at a time.

How GenMeno evaluates supplements
Every product goes through the same independent scoring process before we publish. We evaluate across four dimensions: evidence and formulation, safety and transparency, user experience, and market validation.
Affiliate links, brand samples, and commercial relationships do not determine how a product is evaluated. Every score reflects the product, not the relationship.
Winther, Rein, and Hedman, Climacteric (2005) · Fait, Sailer, and Regidor, Gynecological Endocrinology (2019) · Biglia et al., GREM review of purified cytoplasmic pollen extract (2022) · Johnson, Roberts, and Elkins, Complementary and Alternative Medicine for Menopause (2019) · Goldstein, Espié, and Druckmann, Menopause (2015) · Hellstrom and Muntzing, Menopause (2012) — pollen extract confirmed non-estrogenic in laboratory and clinical analysis · De Franciscis et al., Current Pharmaceutical Design (2020) — 6-month observational study comparing pollen extract and soy isoflavones on menopausal symptoms and sleep
Related reads
Get notified when we publish a new review. No general newsletter, just the review alert.
You're on the list.
We'll reach out when the next review is published.
Tell us what you're looking at. We'll add it to our list and notify you when the review is published.
Got it.
We'll reach out when the review is published.

